TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
INVO Fertility ( (IVF) ) has provided an update.
On July 28, 2025, an institutional investor of INVO Fertility exercised its right to acquire 200 shares of Series C-2 Convertible Preferred Stock for $200,000, adjusting the conversion price to $1.8909 per share. This transaction was conducted without public offering registration, potentially impacting the company’s financial structure and market positioning.
The most recent analyst rating on (IVF) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on INVO Fertility stock, see the IVF Stock Forecast page.
Spark’s Take on IVF Stock
According to Spark, TipRanks’ AI Analyst, IVF is a Underperform.
INVO Fertility’s overall stock score is primarily driven by its poor financial performance and negative technical indicators. While recent corporate events suggest potential capital expansion, the company’s high leverage and lack of profitability are significant concerns.
To see Spark’s full report on IVF stock, click here.
More about INVO Fertility
INVO Fertility, Inc. operates in the fertility industry, focusing on innovative reproductive technologies and services.
Average Trading Volume: 1,489,664
Technical Sentiment Signal: Sell
Current Market Cap: $1.69M
Find detailed analytics on IVF stock on TipRanks’ Stock Analysis page.